Ezetimibe/Rosuvastatin Zinc

依折麦布/瑞舒伐他汀锌

Report date: 2025/02/07 11:48:35
NME

Base Information

Drug NameEzetimibe/Rosuvastatin Zinc
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionNiemann-Pick C1-like protein 1 inhibitorsCholesterol absorption inhibitorsHMG-CoA reductase inhibitors
TargetsNiemann-Pick C1-like protein 1HMG-CoA reductase
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryEU
CombinationsYes EzetimibeRosuvastatin Zinc
Global Highest StatusWithdrawn
Highest Status in ChinaN/A
Originator CompaniesEgis Pharmaceuticals PLC
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEgis Pharmaceuticals PLC
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeC10BA
Related LinksN/A